戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ve been detected in patients with hereditary papillary renal cell carcinoma.
2 not by clear cell renal cell carcinoma or by papillary renal cell carcinomas.
3 f the MET gene have been identified in human papillary renal cell carcinomas.
4 of the proteins that become fused to TFE3 in papillary renal cell carcinomas.
5 to translocation partners on 1 and X in some papillary renal cell carcinomas.
6 e RCC samples, including both clear cell and papillary renal cell carcinomas.
7 X;1)(p11.2;q21.2) has been observed in human papillary renal cell carcinomas.
8 shown to play a role in 13% of patients with papillary renal cell carcinoma and no family history of
9 the histopathology of 103 bilateral archival papillary renal cell carcinomas and 4 metastases in 29 p
10 is known about the genetic basis of sporadic papillary renal-cell carcinoma, and no effective forms o
11                                              Papillary renal cell carcinomas are associated with chro
12                          Furthermore, type 2 papillary renal-cell carcinoma consisted of at least thr
13  metastases in 29 patients from 6 hereditary papillary renal cell carcinoma families with germline c-
14 roliferative cells, resembling precursors of papillary renal cell carcinoma, formed in these proximal
15                               Clear cells of papillary renal cell carcinoma had small basophilic nucl
16 ma type 1 histology, not all type 1 sporadic papillary renal cell carcinomas harbor c-met mutations.
17                             We conclude that papillary renal cell carcinoma patients with c-met mutat
18  mutants previously identified in hereditary papillary renal cell carcinoma patients.
19 ycogen were focally present in tumors of 94% papillary renal cell carcinoma patients.
20               Purpose Patients with advanced papillary renal cell carcinoma (PRCC) have limited thera
21                                              Papillary renal cell carcinoma (pRCC) is an important su
22  of a recently proposed subclassification of papillary renal cell carcinoma (PRCC) that designates tu
23            Despite the moderate incidence of papillary renal cell carcinoma (PRCC), there is a dispro
24  in MET have been described in patients with papillary renal cell carcinoma (PRCC).
25                         In hereditary type 2 papillary renal cell carcinoma (PRCC2, also known as her
26          The histomorphological subtyping of papillary renal cell carcinomas (pRCCs) has improved the
27 omarkers to diagnose malignant clear cell or papillary renal cell carcinoma (RCC) in a screening para
28                                              Papillary renal cell carcinoma (RCC) represents 10% to 1
29                                  A subset of papillary renal cell carcinomas (RCC) is characterized b
30  translocation t(X;1)(p11.2;p34) observed in papillary renal cell carcinomas results in the fusion of
31 thermore, post hoc analysis of human class 1 papillary renal cell carcinoma revealed reduced Notch ac
32 od vessels and in the basement membrane of a papillary renal cell carcinoma, strong FGF-7 binding is
33 as observed in a distinct subgroup of type 2 papillary renal-cell carcinomas that was characterized b
34                                           In papillary renal cell carcinomas the TFE3 transcription f
35 l cell carcinomas with c-met mutations share papillary renal cell carcinoma type 1 histology, not all
36 chitecture and showed chromophil basophilic, papillary renal cell carcinoma type 1 histology.
37 umors with c-met genotype show a distinctive papillary renal cell carcinoma type 1 phenotype and are
38 ve molecular characterization of 161 primary papillary renal-cell carcinomas, using whole-exome seque
39                            Type 1 and type 2 papillary renal-cell carcinomas were shown to be clinica
40                            Type 1 and type 2 papillary renal-cell carcinomas were shown to be differe
41                                              Papillary renal-cell carcinoma, which accounts for 15 to
42                        The histopathology of papillary renal cell carcinoma with c-met mutations has
43 families with germline c-met mutations and 6 papillary renal cell carcinomas with c-met mutations fro
44         Although all hereditary and sporadic papillary renal cell carcinomas with c-met mutations sha
45                                          All papillary renal cell carcinomas with c-met mutations wer

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。